GB2072504B - Pharmaceutical compositions - Google Patents
Pharmaceutical compositionsInfo
- Publication number
- GB2072504B GB2072504B GB8010406A GB8010406A GB2072504B GB 2072504 B GB2072504 B GB 2072504B GB 8010406 A GB8010406 A GB 8010406A GB 8010406 A GB8010406 A GB 8010406A GB 2072504 B GB2072504 B GB 2072504B
- Authority
- GB
- United Kingdom
- Prior art keywords
- pharmaceutical compositions
- pharmaceutical
- compositions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB8010406A GB2072504B (en) | 1980-03-27 | 1980-03-27 | Pharmaceutical compositions |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB8010406A GB2072504B (en) | 1980-03-27 | 1980-03-27 | Pharmaceutical compositions |
Publications (2)
Publication Number | Publication Date |
---|---|
GB2072504A GB2072504A (en) | 1981-10-07 |
GB2072504B true GB2072504B (en) | 1983-10-26 |
Family
ID=10512444
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB8010406A Expired GB2072504B (en) | 1980-03-27 | 1980-03-27 | Pharmaceutical compositions |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB2072504B (en) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0089948B1 (en) * | 1981-10-05 | 1985-08-14 | COPPEN, Alec James | Pharmaceutical compositions |
GB2133285A (en) * | 1983-01-12 | 1984-07-25 | Alec James Coppen | Pharmaceutical compositions |
IT1229517B (en) * | 1989-01-31 | 1991-09-03 | Bioresearch Spa | USE OF 5-METHYLTETRAHYDROPHOLIC ACID, OF 5 FORMYLTHETRAHYDROPHOLIC ACID, AND OF THEIR PHARMACEUTICALLY ACCEPTABLE SALTS FOR THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS IN THE FORM OF CONTROLLED RELEASE SUITABLE FOR BEING EMPLOYED IN THE TREATMENT OF DISORDERS IN THE TREATMENT OF DISORDERS. |
IT1229203B (en) * | 1989-03-22 | 1991-07-25 | Bioresearch Spa | USE OF 5 METHYLTHETRAHYDROPHOLIC ACID, 5 FORMYLTHETRAHYDROPHOLIC ACID AND THEIR PHARMACEUTICALLY ACCEPTABLE SALTS FOR THE PREPARATION OF PHARMACEUTICAL COMPOSITIONS IN THE FORM OF CONTROLLED RELEASE ACTIVE IN THE THERAPY OF MENTAL AND ORGANIC DISORDERS. |
TW361279U (en) * | 1995-01-31 | 1999-06-11 | Wilson Sporting Goods Co Ltd | Shaft for a golf club, set of golf clubs and method of selecting shafts |
GB2336534A (en) * | 1998-04-24 | 1999-10-27 | Alec James Coppen | Anti-depressant - Folic Acid Combination |
JP2002512965A (en) * | 1998-04-24 | 2002-05-08 | スカリスタ リミティッド | Treatment of depression and pharmaceutical preparations therefor |
FR2816944B1 (en) * | 2000-11-17 | 2005-10-21 | Dospharma | NOVEL LITHIUM SALTS, PHARMACEUTICAL COMPOSITIONS BASED ON THESE LITHIUM SALTS AND THEIR APPLICATIONS AS A MEDICINAL PRODUCT |
EP1319663A1 (en) * | 2001-12-17 | 2003-06-18 | Dospharma S.A. | Antidepressant folic -, folinic- and glutamic-acid lithium salts |
AU2007299726A1 (en) * | 2006-09-22 | 2008-03-27 | Braincells, Inc. | Combination comprising an HMG-COA reductase inhibitor and a second neurogenic agent for treating a nervous system disorder and increasing neurogenesis |
RU2717343C1 (en) * | 2019-03-01 | 2020-03-23 | Евгений Владимирович Плотников | Agent possessing cytoprotective action |
-
1980
- 1980-03-27 GB GB8010406A patent/GB2072504B/en not_active Expired
Also Published As
Publication number | Publication date |
---|---|
GB2072504A (en) | 1981-10-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA813465B (en) | Pharmaceutical composition | |
GB8326565D0 (en) | Pharmaceutical compositions | |
GB8327612D0 (en) | Pharmaceutical compositions | |
ZA824622B (en) | Pharmaceutical compositions | |
ZA81136B (en) | Pharmaceutical compositions | |
ZA825397B (en) | Pharmaceutical compositions | |
GB2118176B (en) | Pharmaceutical compositions | |
ZA822856B (en) | Pharmaceutical compositions | |
GB2117766B (en) | Pharmaceutical compositions | |
GB8324133D0 (en) | Pharmaceutical compositions | |
GB2072504B (en) | Pharmaceutical compositions | |
ZA82652B (en) | Pharmaceutical compositions | |
ZA815700B (en) | Pharmaceutical compositions | |
GB8313814D0 (en) | Pharmaceutical compositions | |
DE3377696D1 (en) | Pharmaceutical compositions | |
GB2114001B (en) | Nasel pharmaceutical compositions | |
IL62432A0 (en) | Pharmaceutical compositions based on sulphonamide-potentiator combinations | |
ZA817684B (en) | Pharmaceutical compositions | |
DE3176849D1 (en) | Pharmaceutical composition comprising 4-carbamoyl-imidazolium-5-olate | |
ZA814056B (en) | Pharmaceutical bicyclo-octatriene compounds and compositions | |
ZA826477B (en) | Pharmaceutical compositions | |
ZW18582A1 (en) | Pharmaceutical compositions | |
GB8305028D0 (en) | Pharmaceutical compositions | |
GB8314736D0 (en) | Pharmaceutical compositions | |
ZA815175B (en) | Pharmaceutical composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
727 | Application made for amendment of specification (sect. 27/1977) | ||
727A | Application for amendment of specification now open to opposition (sect. 27/1977) | ||
727B | Case decided by the comptroller ** specification amended (sect. 27/1977) | ||
SP | Amendment (slips) printed | ||
PCNP | Patent ceased through non-payment of renewal fee |
Effective date: 19990327 |